– UK, London –  Block Commodities Ltd (LON: BLCC) today announced the appointment of Ian Tordoff as CEO who has joined the Board with immediate effect. Mr Tordoff will assume responsibility for the overall management of business operations from Dr Chris Cleverly, who will step down from his executive role but remain in his position as non-executive Chairman of the Company.

Chris Cleverly, non-executive Chairman of Block Commodities, said: “Block Commodities has reached an exciting new stage in its development and has subsequently strengthened its leadership team to meet the opportunities presented by the changing commercial and regulatory landscapes. The substantial growth opportunity that exists for the company was exemplified by the NHS approval of two cannabis-based medicines for use by the National Institute for Health and Care Excellence in the UK. We welcome the wealth of experience that Ian brings to the Company from the health and wellness industry and look forward to working with him.”

About Ian Tordoff

Mr Tordoff has wide expertise in leading engineering and logistics development teams. He has managed more than US$6bn of health care projects, spanning clinical & medical assignments in the UK, US and Middle East for health providers and insurance clients.

Formerly a consultant for Ernst & Young, Ian has since held Non-executive Director and advisory roles with the National Health Service, myHealthPal Group and Dermaltech. He currently advises PathologyCloud, Amethyst Radiotherapy and Vulcan Industries PLC.

Ian’s extensive experience has involved tracking the evidence base for the efficacy of cannabidiol and tetrahydrocannabinol, two natural compounds found in cannabis plants and their associated treatments and he has built strong relationships through this work with relevant producers, labs, “brands” and customers.

Ian Tordoff, CEO of Block Commodities said: “I am pleased to join Block Commodities at such a pivotal time for the Company. Black Commodities is well placed to build a market-leading position in the sector. I am looking forward to expanding both our Advisory Board and Medical Management Team in the next two quarters to ensure that we have the best in-house resources to capitalise on the emerging opportunities in this rapidly developing market, to the benefit of all of our stakeholders.”

For more information: http://www.blockcommodities.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.